Error loading player: No playable sources found

AM24-MN-35-O

AM24-MN-35-O: The Role of Blood Operators and Transfusion Services in Preventing and Responding to Transfusion-transmitted Malaria (Enduring)

Date
October 23, 2024
Credits
1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP) | 1 Physician (PHY)
$30
Standard Price
Members save $5
This product is also available as part of the following products:
Thumbnail for 2024 Annual Meeting On-Demand: FULL ACCESS
By far the best value to watch all the on-demand educational sessions from the 2024 AABB Annual Meeting and earn continuing education credit…

Malaria is caused by intra erythrocytic parasites from the genus Plasmodium. In the natural world, Plasmodium is transmitted to humans via the bite of an infected female Anopheles mosquito. Autochthonous cases occur sporadically in Europe and the United States, yet malaria in Western countries usually occurs after travel/residence in an endemic region. Asymptomatic blood donors are a source of Plasmodium infected erythrocytes- leading to transfusion-transmitted malaria (TTM)- usually from whole blood, and red blood cell concentrates (RBC). TTM is rare yet lead to more severe disease/death than natural infection if not timely managed. Global climate change and shifting malaria epidemiology challenges blood operators and transfusion medicine practitioners. In non-endemic regions, TTM can be overlooked by clinicians and laboratorians. Blood donor screening questions focussed on malaria disease have poor sensitivity/specificity. Serologic donor testing has strengths and weaknesses and only modest uptake worldwide. Most industrialized countries lack regulator-approved Plasmodium nucleic acid screening tests (NAT). Questions exist on whether NATs can detect the lowest infectious dose of Plasmodium in blood products. Clinicians may lack strategies on managing healthy donors with Plasmodium positive test results from a blood operator. The session will provide unique perspectives from a blood operator working in a region with re-emergent endemic malaria and a transfusion medicine specialist investigating a pediatric TTM in a non-emergent region. Attendees will be engaged using polling questions and a Q&A period. Response to polling questions and general comments will be documented used in other knowledge translation activities. Attendees will develop insights on how to plan for changing malaria epidemiology, evaluate malaria transfusion-transmission risk mitigation options, and educate the broader medical/scientific community on transfusion-transmitted malaria.

Learning Objectives

  • Identify factors involved in changing malaria epidemiology
  • Contrast current malaria risk deferral recommendations in the US and selected countries and how they are implemented in donor centers
  • Propose approaches focused on educating the larger medical community on TTM
  • Summarize information on the first donor screening malaria test licensed by the US Food and Drug Administration.

Moderator

Speaker Image for Steven Drews
Steven J. Drews, PhD, FCCM, D(ABMM)
Donation Policy and Studies, Canadian Blood Services; Professor, Division of Diagnostic and Applied Microbiology, University of Alberta, Edmonton, AB, Canada.

Speakers

Speaker Image for Susan Nahirniak
Susan Nahirniak, MD, FRCPC
Transfusion and Transplantation Medicine, Alberta Precision Laboratories & Laboratory Medicine & Pathology, University of Alberta

Related Products

Thumbnail for AM24-SN-21-O: Beyond Gender-Based Sexual Activity Blood Safety Rules - Outcomes and Next Steps (Enduring)
AM24-SN-21-O: Beyond Gender-Based Sexual Activity Blood Safety Rules - Outcomes and Next Steps (Enduring)
Testing and pathogen reduction technologies have improved substantially since implementation of donor deferral policies in the 1980s relating to gay, bisexual, and other men who had sex with men (gbMSM)…
Thumbnail for AM24-SN-05-O: Ensuring Blood Availability for Mass Casualty Events (Enduring)
AM24-SN-05-O: Ensuring Blood Availability for Mass Casualty Events (Enduring)
Until recently, there was no coordinated effort to ensure blood would be available in times of mass casualty events…
Thumbnail for AM24-MN-33-O: Resilience Explored: Navigating Post-Pandemic Blood Products Utilization Trends and Supply Challenges in North America (Enduring)
AM24-MN-33-O: Resilience Explored: Navigating Post-Pandemic Blood Products Utilization Trends and Supply Challenges in North America (Enduring)
This educational session presents a comprehensive exploration of post-pandemic blood utilization trends and supply challenges in North America, featuring experts from prominent blood suppliers with a national footprint—the American Red Cross, Canadian Blood Services, and Vitalant…
Thumbnail for AM24-MN-22-O: What is the Status of the U.S. Blood Supply? Preliminary Findings of the 2023 NBCUS and Latest Trends From Blood Collectors (Enduring)
AM24-MN-22-O: What is the Status of the U.S. Blood Supply? Preliminary Findings of the 2023 NBCUS and Latest Trends From Blood Collectors (Enduring)
The biennially conducted National Blood Collection and Utilization Survey (NBCUS) provides the most comprehensive estimation of blood collection and utilization in the United States…